For richer charts and full features, open SpikePanel on desktop.
Graded daily on value D-, growth A, profitability B-, momentum D-, revisions C+. Sector-relative, identical for every user.
Pro Analysis Available: Full unrolled post citations, institutional 13F filing matrix, and real-time sentiment alerts for $AXON are available with SpikePanel Pro.
Key events, in time order
Biggest bet ever disclosed in earnings; AI adoption and software growth alongside
Missed estimates and federal counter-drone delays prompt lowered full-year outlook
New device boosts AI processing and battery life for real-time field assistance
State corrections adopt Axon body cameras; reports show 40% reduction in physical assaults on staff
Subsidiary Marrero Armor lands first international order, expanding global reach of U.S.-made ballistic protection
Company confirms pricing of offering; market concerns over dilution and debt load weigh on shares.
Post-earnings drop attracts multiple independent investors to initiate/add positions, citing support levels
Q2 revenue up 35% YoY, 10th straight quarter of 30%+ growth; stock up over 30x since early 2016
全年营收指引上调至同比增长 32%-34%，较此前 30%-32% 上调 200 个基点。
全年营收指引上调至同比增长 32%-34%，较此前 30%-32% 上调 200 个基点。
全年营收指引上调至同比增长 32%-34%，较此前 30%-32% 上调 200 个基点。
Amundi's 13F filing shows reduced position, adding to institutional selling trend
Institutional quarterly holding change reflects capital flow
None yet
None yet
Cases AI-clustered from trusted X authors over 2 weeks; counts are distinct authors. Volume does not predict direction · Not investment advice
No comments yet.
Facts and opinions separated · All items sourced · Not investment advice